Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1989 2
1990 1
1993 1
1996 1
1997 2
1998 2
1999 3
2000 3
2001 3
2002 2
2003 1
2004 3
2005 1
2006 6
2007 2
2008 4
2009 2
2010 1
2012 2
2013 4
2014 4
2015 6
2018 3
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 17051898

54 results
Results by year
Filters applied: . Clear all
Page 1
Chronic polysystemic candidiasis as a possible contributor to onset of idiopathic Parkinson's disease.
Epp LM, Mravec B. Epp LM, et al. Bratisl Lek Listy. 2006;107(6-7):227-30. Bratisl Lek Listy. 2006. PMID: 17051898 Review.
Isolation and Sequencing of Salsolinol Synthase, an Enzyme Catalyzing Salsolinol Biosynthesis.
Chen X, Zheng X, Ali S, Guo M, Zhong R, Chen Z, Zhang Y, Qing H, Deng Y. Chen X, et al. ACS Chem Neurosci. 2018 Jun 20;9(6):1388-1398. doi: 10.1021/acschemneuro.8b00023. Epub 2018 Apr 12. ACS Chem Neurosci. 2018. PMID: 29602279
Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.
Zheng X, Chen X, Guo M, Ali S, Huang Y, Sun F, Liu K, Chen Z, Deng Y, Zhong R. Zheng X, et al. Neurosci Lett. 2018 Apr 23;673:39-43. doi: 10.1016/j.neulet.2018.02.024. Epub 2018 Feb 15. Neurosci Lett. 2018. PMID: 29454627
N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
Naoi M, Maruyama W, Dostert P, Hashizume Y. Naoi M, et al. J Neural Transm Suppl. 1997;50:89-105. doi: 10.1007/978-3-7091-6842-4_10. J Neural Transm Suppl. 1997. PMID: 9120428 Review.
[Pathogenesis of idiopathic Parkinson's disease].
Maruyama W. Maruyama W. Nihon Ronen Igakkai Zasshi. 2001 Jul;38(4):494-7. doi: 10.3143/geriatrics.38.494. Nihon Ronen Igakkai Zasshi. 2001. PMID: 11523160 Free article. Japanese.
Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines.
Antkiewicz-Michaluk L. Antkiewicz-Michaluk L. Pol J Pharmacol. 2002 Nov-Dec;54(6):567-72. Pol J Pharmacol. 2002. PMID: 12866710 Free article. Review.
Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
Naoi M, Maruyama W, Nagy GM. Naoi M, et al. Neurotoxicology. 2004 Jan;25(1-2):193-204. doi: 10.1016/S0161-813X(03)00099-8. Neurotoxicology. 2004. PMID: 14697894 Review.
Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein.
Wanpen S, Govitrapong P, Shavali S, Sangchot P, Ebadi M. Wanpen S, et al. Brain Res. 2004 Apr 16;1005(1-2):67-76. doi: 10.1016/j.brainres.2004.01.054. Brain Res. 2004. PMID: 15044066
Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic transmission: a review of recent developments.
Mravec B. Mravec B. Physiol Res. 2006;55(4):353-64. Epub 2005 Oct 17. Physiol Res. 2006. PMID: 16238467 Free article. Review.
Oxidative and nitrative protein modifications in Parkinson's disease.
Danielson SR, Andersen JK. Danielson SR, et al. Free Radic Biol Med. 2008 May 15;44(10):1787-94. doi: 10.1016/j.freeradbiomed.2008.03.005. Epub 2008 Mar 18. Free Radic Biol Med. 2008. PMID: 18395015 Free PMC article. Review.
54 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page